HealthTree Logo
search more_vert
App Logo
close
person Sign In / Create Account
Key Answers for Smoldering Myeloma Patients
Posted: Jul 12, 2014
Key Answers for Smoldering Myeloma Patients image
Patient Power

has created a very helpful series of videos to answer important questions posed by myeloma patients. Here are key questions that are critical to smoldering myeloma patients, answered by Dr. Robert Orlowski, MD, PhD of the MD Anderson Cancer Center. Watching and Waiting for Smoldering Myeloma: What Tests and When?

Can Anything Stop MGUS and Smoldering Myeloma from Progressing to Symptomatic Disease?
What Clinical Trials are Available for Smoldering Myeloma Patients?
 

The author Jennifer Ahlstrom

about the author
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of HealthTree Foundation (formerly Myeloma Crowd). 

More on New in Myeloma

ASCO 2023: A New Bi-Specific Therapy Combination for Relapsed or Refractory Myeloma Patients image
ASCO 2023: A New Bi-Specific Therapy Combination for Relapsed or Refractory Myeloma Patients
ASCO 2023: Comparing BLENREP (belantamab-mafodotin) to POMALYST (pomalidomide) and dex image
ASCO 2023: Comparing BLENREP (belantamab-mafodotin) to POMALYST (pomalidomide) and dex
ASCO 2023: The Ground-Breaking Combination of Two Bi-specific Antibody Therapies image
ASCO 2023: The Ground-Breaking Combination of Two Bi-specific Antibody Therapies
ASCO 2023: A New BCMA-Targeting Bi-specific Antibody, Linvoseltamab image
ASCO 2023: A New BCMA-Targeting Bi-specific Antibody, Linvoseltamab
ASCO 2023: A New Induction Therapy for Newly Diagnosed Myeloma image
ASCO 2023: A New Induction Therapy for Newly Diagnosed Myeloma
ASCO 2023: The New T-Charged CAR on the Block: PHE885 image
ASCO 2023: The New T-Charged CAR on the Block: PHE885
See More

Trending Articles

Kappa and Lambda Light Chains Kappa and Lambda Light Chains
ASCO 2023: Benefits of Exercise for Multiple Myeloma Patients ASCO 2023: Benefits of Exercise for Multiple Myeloma Patients
ASCO 2023: A Maintenance Regimen for High-Risk Myeloma ASCO 2023: A Maintenance Regimen for High-Risk Myeloma
Understanding the 2023 ASCO Annual Meeting: What Do Patients Need to Know? Understanding the 2023 ASCO Annual Meeting: What Do Patients Need to Know?
ASCO 2023: The New T-Charged CAR on the Block: PHE885 ASCO 2023: The New T-Charged CAR on the Block: PHE885

Upcoming Events

The Science and Art of Creating Your Personalized Myeloma Treatment Strategy with Dr. Murali Janakiram, City of Hope

The Science and Art of Creating Your Personalized Myeloma Treatment Strategy with Dr. Murali Janakiram, City of Hope

Jun 13 / 18:00 PDT
GPRC5D and FCRH5 Targeted Therapies in Myeloma

GPRC5D and FCRH5 Targeted Therapies in Myeloma

Jun 15 / 13:00 EDT
Probing the Myeloma Immune MicroEnvironment One Cell at A Time (Single-Cell Sequencing)

Probing the Myeloma Immune MicroEnvironment One Cell at A Time (Single-Cell Sequencing)

Jun 21 / 13:00 EDT

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Janssen Oncology
Adaptive Biotechnologies
Amgen Oncology
Abbvie
Genentech
Bristol Myers Squibb

Follow Us

facebook instagram twitter youtube

 https://www.guidestar.org/profile/45-5354811

HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization.

Copyright © 2022 HealthTree Foundation. All rights reserved.

Tax ID 45-5354811